- Home
- ELDN vs DRTS Comparison
ELDN vs DRTS Comparison
Compare ELDN & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- DRTS
- Stock Information
- Founded
- ELDN 2004
- DRTS 2015
- Country
- ELDN United States
- DRTS Israel
- Employees
- ELDN N/A
- DRTS N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- DRTS Medical/Dental Instruments
- Sector
- ELDN Health Care
- DRTS Health Care
- Exchange
- ELDN Nasdaq
- DRTS Nasdaq
- Market Cap
- ELDN 178.4M
- DRTS 211.7M
- IPO Year
- ELDN N/A
- DRTS N/A
- Fundamental
- Price
- ELDN $2.89
- DRTS $2.95
- Analyst Decision
- ELDN Strong Buy
- DRTS Strong Buy
- Analyst Count
- ELDN 1
- DRTS 2
- Target Price
- ELDN $16.00
- DRTS $8.00
- AVG Volume (30 Days)
- ELDN 160.2K
- DRTS 27.4K
- Earning Date
- ELDN 05-20-2025
- DRTS 05-19-2025
- Dividend Yield
- ELDN N/A
- DRTS N/A
- EPS Growth
- ELDN N/A
- DRTS N/A
- EPS
- ELDN N/A
- DRTS N/A
- Revenue
- ELDN N/A
- DRTS N/A
- Revenue This Year
- ELDN N/A
- DRTS N/A
- Revenue Next Year
- ELDN N/A
- DRTS N/A
- P/E Ratio
- ELDN N/A
- DRTS N/A
- Revenue Growth
- ELDN N/A
- DRTS N/A
- 52 Week Low
- ELDN $2.00
- DRTS $1.75
- 52 Week High
- ELDN $5.54
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- ELDN 40.93
- DRTS 68.40
- Support Level
- ELDN $2.85
- DRTS $2.50
- Resistance Level
- ELDN $3.51
- DRTS $2.96
- Average True Range (ATR)
- ELDN 0.27
- DRTS 0.15
- MACD
- ELDN -0.01
- DRTS 0.04
- Stochastic Oscillator
- ELDN 5.63
- DRTS 97.83
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.